Childrenthese patients mayget paradoxicalexcitement fromH1 Gen receptorantagonistsp. 641asthma actionplan specifyingaction to take ifsx worsen p653Collaboratew/provider1stGenerationH1 ReceptorAntagonistsneed to ask ptsabout glaucoma,peptic ulcer dis.pregnancy &urinary retentionb/4 use p 640beta-adrenergicblockersinhibitbronchodilationand may inducebronchospasmin pts takingalbuterol p. 659Albuterol(proventil)AdrenergicBronchodilatorprototype)MAOinhibitorsand beta-adrenergicblockersused togetherwithin 14 dayscouldprecipitatehypertensivecrisis p 659Long ActingMaintenancemedsmore likely tobe combinedwith a steroidp 657)3rdGenerationH1 ReceptorAntagonists'Azole' anitfungals(fluconazole,ketoconazole,miconazole) &Macrolides increaseits concentration p.6461st chemicalmediatorreleased inimmune &inflammatoryresponseHistaminep. 635Epinephrineinhaled selective beta2-agonist would bedrug of choice in lieuof the one showingdue to beta-stimulation andincreased heart rate& force of contractionwheezingcaused byturbulent airflow thruobstructedairway p. 653Promethazinemay cause fatalrespiratorydepression inchildren < 2yop. 642statusasthmaticusbronchodilatorfirst, followedby steroidrapid IVinjection ofanithistamineseverehypotensionmay resultp 642worksynergisticallywithadrenergicbronchodiltorsanticholinergics- ineffective atrelievingbronchospasmalone p 661PEFRPeakexpiratoryflow ratep. 653FDABlack BoxWarningissued forPromethazine dueto chemicalirritation & tissuedamageregardless of routeof admin p. 642IpratropiumAtrovent)AnticholinergicPrototypeDiphenhydramine(Benadryl)shouldn't be takenwithin 14 days ofMAO inhibitor -risk ofoverstimulatingsympathetic nvssystem p. 640Inhalershake wellbefore use holdbreath x 10 sec,exhale slowlyand rinse mouthp 660salmeterolInitiating thisduringworsening sxmay be life-threatening p660CNSstimulationagitation, anxiety,insomnia, Sz,tremors, seriousdysrhythmia andcardiac arrestp 657excessiveCNS/cardiacstimulationmain riskw/adrenergicbronchodilatorsp. 657Viral infections,EnvironmentalfactorsNSAIDS's,sulfitesTriggersforasthma p.652Childrenthese patients mayget paradoxicalexcitement fromH1 Gen receptorantagonistsp. 641asthma actionplan specifyingaction to take ifsx worsen p653Collaboratew/provider1stGenerationH1 ReceptorAntagonistsneed to ask ptsabout glaucoma,peptic ulcer dis.pregnancy &urinary retentionb/4 use p 640beta-adrenergicblockersinhibitbronchodilationand may inducebronchospasmin pts takingalbuterol p. 659Albuterol(proventil)AdrenergicBronchodilatorprototype)MAOinhibitorsand beta-adrenergicblockersused togetherwithin 14 dayscouldprecipitatehypertensivecrisis p 659Long ActingMaintenancemedsmore likely tobe combinedwith a steroidp 657)3rdGenerationH1 ReceptorAntagonists'Azole' anitfungals(fluconazole,ketoconazole,miconazole) &Macrolides increaseits concentration p.6461st chemicalmediatorreleased inimmune &inflammatoryresponseHistaminep. 635Epinephrineinhaled selective beta2-agonist would bedrug of choice in lieuof the one showingdue to beta-stimulation andincreased heart rate& force of contractionwheezingcaused byturbulent airflow thruobstructedairway p. 653Promethazinemay cause fatalrespiratorydepression inchildren < 2yop. 642statusasthmaticusbronchodilatorfirst, followedby steroidrapid IVinjection ofanithistamineseverehypotensionmay resultp 642worksynergisticallywithadrenergicbronchodiltorsanticholinergics- ineffective atrelievingbronchospasmalone p 661PEFRPeakexpiratoryflow ratep. 653FDABlack BoxWarningissued forPromethazine dueto chemicalirritation & tissuedamageregardless of routeof admin p. 642IpratropiumAtrovent)AnticholinergicPrototypeDiphenhydramine(Benadryl)shouldn't be takenwithin 14 days ofMAO inhibitor -risk ofoverstimulatingsympathetic nvssystem p. 640Inhalershake wellbefore use holdbreath x 10 sec,exhale slowlyand rinse mouthp 660salmeterolInitiating thisduringworsening sxmay be life-threatening p660CNSstimulationagitation, anxiety,insomnia, Sz,tremors, seriousdysrhythmia andcardiac arrestp 657excessiveCNS/cardiacstimulationmain riskw/adrenergicbronchodilatorsp. 657Viral infections,EnvironmentalfactorsNSAIDS's,sulfitesTriggersforasthma p.652

HSC 204 Ch 32_33 Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. these patients may get paradoxical excitement from H1 Gen receptor antagonists p. 641
    Children
  2. Collaborate w/provider
    asthma action plan specifying action to take if sx worsen p 653
  3. need to ask pts about glaucoma, peptic ulcer dis. pregnancy & urinary retention b/4 use p 640
    1st Generation H1 Receptor Antagonists
  4. inhibit bronchodilation and may induce bronchospasm in pts taking albuterol p. 659
    beta-adrenergic blockers
  5. Adrenergic Bronchodilator prototype)
    Albuterol (proventil)
  6. used together within 14 days could precipitate hypertensive crisis p 659
    MAO inhibitors and beta-adrenergic blockers
  7. more likely to be combined with a steroid p 657)
    Long Acting Maintenance meds
  8. 'Azole' anitfungals (fluconazole, ketoconazole, miconazole) & Macrolides increase its concentration p. 646
    3rd Generation H1 Receptor Antagonists
  9. Histamine p. 635
    1st chemical mediator released in immune & inflammatory response
  10. inhaled selective beta 2-agonist would be drug of choice in lieu of the one showing due to beta- stimulation and increased heart rate & force of contraction
    Epinephrine
  11. caused by turbulent air flow thru obstructed airway p. 653
    wheezing
  12. may cause fatal respiratory depression in children < 2yo p. 642
    Promethazine
  13. bronchodilator first, followed by steroid
    status asthmaticus
  14. severe hypotension may result p 642
    rapid IV injection of anithistamine
  15. anticholinergics - ineffective at relieving bronchospasm alone p 661
    work synergistically with adrenergic bronchodiltors
  16. Peak expiratory flow rate p. 653
    PEFR
  17. issued for Promethazine due to chemical irritation & tissue damage regardless of route of admin p. 642
    FDA Black Box Warning
  18. Anticholinergic Prototype
    Ipratropium Atrovent)
  19. shouldn't be taken within 14 days of MAO inhibitor - risk of overstimulating sympathetic nvs system p. 640
    Diphenhydramine (Benadryl)
  20. shake well before use hold breath x 10 sec, exhale slowly and rinse mouth p 660
    Inhaler
  21. Initiating this during worsening sx may be life-threatening p 660
    salmeterol
  22. agitation, anxiety, insomnia, Sz, tremors, serious dysrhythmia and cardiac arrest p 657
    CNS stimulation
  23. main risk w/adrenergic bronchodilators p. 657
    excessive CNS/cardiac stimulation
  24. Triggers for asthma p. 652
    Viral infections, Environmental factors NSAIDS's, sulfites